Radha Rama Devi Akella, Ganapathy Aparna, Mannan Ashraf U, Sabharanjak Shefali, Naushad Shaik M
Rainbow Children's Hospital, Strand Life Sciences, Bangalore, Hyderabad, India.
Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Bangalore, India.
Mol Syndromol. 2019 May;10(3):161-166. doi: 10.1159/000496079. Epub 2019 Jan 16.
Chromosome 1q42.12q42.2 deletions are documented as "disease causing" and show overlapping phenotypes depending on the genes involved in the deletion. In this report, we detected a 5.8-Mb deletion encompassing the chromosome 1q42.12q42.2 region in a 4-year-old boy with hypoplastic corpus callosum, epilepsy, developmental delay, microcephaly, cataract, cleft palate, and skeletal changes. The deletion was de novo. Genotype-phenotype correlations suggest that the major features of 1q42.12q42.2 microdeletion were attributed to the genes with a high probability of loss-of-function intolerance score in this deletion, namely , , , , , , , , , , and along with
1号染色体1q42.12q42.2缺失被记录为“致病”,并根据缺失所涉及的基因表现出重叠的表型。在本报告中,我们在一名4岁男孩中检测到一个5.8兆碱基的缺失,该缺失涵盖1号染色体1q42.12q42.2区域,该男孩患有胼胝体发育不全、癫痫、发育迟缓、小头畸形、白内障、腭裂和骨骼改变。该缺失为新发突变。基因型-表型相关性表明,1q42.12q42.2微缺失的主要特征归因于该缺失中功能丧失不耐受评分高的基因,即 、 、 、 、 、 、 、 、 、 以及 。